1. Home
  2. GNFT vs INGN Comparison

GNFT vs INGN Comparison

Compare GNFT & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • INGN
  • Stock Information
  • Founded
  • GNFT 1999
  • INGN 2001
  • Country
  • GNFT France
  • INGN United States
  • Employees
  • GNFT N/A
  • INGN N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • INGN Industrial Specialties
  • Sector
  • GNFT Health Care
  • INGN Health Care
  • Exchange
  • GNFT Nasdaq
  • INGN Nasdaq
  • Market Cap
  • GNFT 214.5M
  • INGN N/A
  • IPO Year
  • GNFT 2019
  • INGN 2014
  • Fundamental
  • Price
  • GNFT N/A
  • INGN $7.49
  • Analyst Decision
  • GNFT Strong Buy
  • INGN Strong Buy
  • Analyst Count
  • GNFT 1
  • INGN 3
  • Target Price
  • GNFT $13.00
  • INGN $11.00
  • AVG Volume (30 Days)
  • GNFT 4.2K
  • INGN 205.2K
  • Earning Date
  • GNFT 04-24-2025
  • INGN 08-05-2025
  • Dividend Yield
  • GNFT N/A
  • INGN N/A
  • EPS Growth
  • GNFT N/A
  • INGN N/A
  • EPS
  • GNFT 0.03
  • INGN N/A
  • Revenue
  • GNFT $73,187,701.00
  • INGN $339,960,000.00
  • Revenue This Year
  • GNFT $15.98
  • INGN $7.46
  • Revenue Next Year
  • GNFT N/A
  • INGN $6.03
  • P/E Ratio
  • GNFT $125.30
  • INGN N/A
  • Revenue Growth
  • GNFT 105.01
  • INGN 5.73
  • 52 Week Low
  • GNFT $2.55
  • INGN $5.70
  • 52 Week High
  • GNFT $6.42
  • INGN $13.33
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 47.81
  • INGN 68.13
  • Support Level
  • GNFT $3.61
  • INGN $6.86
  • Resistance Level
  • GNFT $3.95
  • INGN $7.30
  • Average True Range (ATR)
  • GNFT 0.14
  • INGN 0.33
  • MACD
  • GNFT -0.01
  • INGN 0.09
  • Stochastic Oscillator
  • GNFT 57.01
  • INGN 92.54

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: